| P50 | author | Niel Hens | Q30105747 |
| | Philippe Beutels | Q30105759 |
| | Lander Willem | Q30105766 |
| | Benson Ogunjimi | Q41050389 |
| P2860 | cites work | THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS | Q24684507 |
| | Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox | Q28111950 |
| | Longitudinal study on oral shedding of herpes simplex virus 1 and varicella-zoster virus in individuals infected with HIV | Q28660303 |
| | Hope-Simpson's progressive immunity hypothesis as a possible explanation for herpes zoster incidence data | Q30610859 |
| | Using empirical social contact data to model person to person infectious disease transmission: an illustration for varicella | Q33403438 |
| | Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine | Q33585318 |
| | Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine | Q33585349 |
| | IE63-specific T-cell responses associate with control of subclinical varicella zoster virus reactivation in individuals with malignancies. | Q33723698 |
| | Herpes zoster recurrences more frequent than previously reported | Q34541849 |
| | Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries | Q34683751 |
| | Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary Review | Q34785366 |
| | Persistence of varicella zoster virus DNA in saliva after herpes zoster | Q35167118 |
| | Subclinical reactivation of varicella zoster virus in all stages of HIV infection | Q35223284 |
| | Varicella prevention in the United States: a review of successes and challenges | Q37258047 |
| | Childhood varicella-zoster virus vaccination in Belgium: cost-effective only in the long run or without exogenous boosting? | Q37521887 |
| | Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians | Q37643309 |
| | Examination of links between herpes zoster incidence and childhood varicella vaccination | Q38423324 |
| | Herpes zoster is associated with herpes simplex and other infections in under 60 year-olds | Q38547514 |
| | The health and economic burden of chickenpox and herpes zoster in Belgium. | Q38549235 |
| | NIH conference. Herpes zoster-varicella infections in immunosuppressed patients | Q40169164 |
| | Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged | Q40610830 |
| | Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine. | Q40709476 |
| | Modelling the impact of immunization on the epidemiology of varicella zoster virus | Q40722872 |
| | Selective decline in cellular immune response to varicella-zoster in the elderly | Q41548624 |
| | Varicella-zoster virus-derived major histocompatibility complex class I-restricted peptide affinity is a determining factor in the HLA risk profile for the development of postherpetic neuralgia | Q41684668 |
| | Serology indicates cytomegalovirus infection is associated with varicella-zoster virus reactivation | Q42247692 |
| | A mathematical model for HIV and hepatitis C co-infection and its assessment from a statistical perspective | Q42273455 |
| | Rapid quantitative PCR assays for the simultaneous detection of herpes simplex virus, varicella zoster virus, cytomegalovirus, Epstein-Barr virus, and human herpesvirus 6 DNA in blood and other clinical specimens | Q43546425 |
| | Immunologic Evidence of Reinfection with Varicella-Zoster Virus | Q43820803 |
| | Development of virus-specific CD4+ T cells on reexposure to Varicella-Zoster virus | Q45627353 |
| | Stress-induced subclinical reactivation of varicella zoster virus in astronauts | Q45708260 |
| | Decline in Varicella‐Zoster Virus (VZV)–Specific Cell‐Mediated Immunity with Increasing Age and Boosting with a High‐Dose VZV Vaccine | Q45710554 |
| | Subclinical reactivation of varicella-zoster virus in immunocompromised and immunocompetent individuals | Q45752763 |
| | Varicella-zoster virus (VZV) reactivation is related to the low response of VZV-specific immunity after chickenpox in infancy | Q45778884 |
| | Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles. | Q51905646 |
| | Closing the gap between T-cell life span estimates from stable isotope-labeling studies in mice and humans | Q59292898 |
| | Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database | Q78304911 |
| | A Prospective Study of the Herpes Zoster Severity of Illness | Q85031555 |
| P407 | language of work or name | English | Q1860 |
| P577 | publication date | 2015-07-11 | |
| P1433 | published in | eLife | Q2000008 |
| P1476 | title | Integrating between-host transmission and within-host immunity to analyze the impact of varicella vaccination on zoster | |
| P478 | volume | 4 | |